In BMC cancer
BACKGROUND : Few highly accurate tests can diagnose central lymph node metastasis (CLNM) of papillary thyroid cancer (PTC). Genetic sequencing of tumor tissue has allowed the targeting of certain genetic variants for personalized cancer therapy development.
METHODS : This study included 488 patients diagnosed with PTC by ultrasound-guided fine-needle aspiration biopsy, collected clinicopathological data, analyzed the correlation between CLNM and clinicopathological features using univariate analysis and binary logistic regression, and constructed prediction models.
RESULTS : Binary logistic regression analysis showed that age, maximum diameter of thyroid nodules, capsular invasion, and BRAF V600E gene mutation were independent risk factors for CLNM, and statistically significant indicators were included to construct a nomogram prediction model, which had an area under the curve (AUC) of 0.778. A convolutional neural network (CNN) prediction model built with an artificial intelligence (AI) deep learning algorithm achieved AUCs of 0.89 in the training set and 0.78 in the test set, which indicated a high prediction efficacy for CLNM. In addition, the prediction models were validated in the subclinical metastasis and clinical metastasis groups with high sensitivity and specificity, suggesting the broad applicability of the models. Furthermore, CNN prediction models were constructed for patients with nodule diameters less than 1 cm. The AUCs in the training set and test set were 0.87 and 0.76, respectively, indicating high prediction efficacy.
CONCLUSIONS : The deep learning-based multifeature integration prediction model provides a reference for the clinical diagnosis and treatment of PTC.
Wang Zhongzhi, Qu Limeng, Chen Qitong, Zhou Yong, Duan Hongtao, Li Baifeng, Weng Yao, Su Juan, Yi Wenjun
2023-Feb-08
BRAF V600E gene mutation, Central lymph node metastasis(CLNM), Convolutional neural network(CNN), Papillary thyroid cancer(PTC)
